A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection (ARSGBTAAD)
A Chinese Registry to Determine the Genetic Risk Factors and Serumal Biomarkers for Thoracic Aortic Aneurysm/Dissection
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Beijing, China, 100029
- Recruiting
- Beijing Anzhen Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Case Inclusion Criteria:
- Subject who was diagnosed as thoracic aortic aneurysm/dissection by CT angiography, interventional angiography or vascular ultrasound;
- Age is less than 80 years old;
- male and non pregnancy female;
- Subject understands study requirements aand agrees to sign an informed consent form prior to any study procedures.
Case Exclusion Criteria:
Subject has one of the following:
- Pseudoaneurysm;
- Previous infection or trauma in the damaged part of aorta;
- Pregnancy female;
- Participate in other clinical trials in the last 1 months.
Control Inclusion Criteria:
- Age and gender are matched with cases;
- No aortic disease was detected by outpatient ultrasound;
- No family history of cardiovascular disease;
- Normal biochemical indicators;
Criteria for culling, shedding and suspension testing:
- Culling: Unqualified cases and controls. Data of culled subjects can not be used for statistical analysis;
- Shedding: Subject that self withdrawal, loss to follow-up, or quitted by doctors; Reasons for shedding should be indicated for each shed subject.
- Suspension: a) The researchers found significant safety problems or wrong study design; b) Researchers cannot continue clinical research due to funding or management reasons; c) Director ends the study. When suspension happens, all the CRF table should be reserved for future reference.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
case
|
|
control
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Age for each participant
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Gender for each participant
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Height for each participant
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Weight for each participant
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Contact information for each participant
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Past Medical History including disease history, surgical history, and family medical history
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Lifestyle including smoking history and drinking, specify how many years smoking or drinking lasted and detail quantity per day
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Exon sequencing data of each participant
Time Frame: Sequencing will be carried out in an average of 3 months after sample recruiting
|
Sequencing will be carried out in an average of 3 months after sample recruiting
|
|
Serum biomarker screening data of each participant
Time Frame: Screening will be carried out in an average of 3 months after sample recruiting
|
Screening will be carried out in an average of 3 months after sample recruiting
|
|
The location of Aneurysm/Dissection
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
The size of Aneurysm/Dissection
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
blood biochemical index:blood lipid
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
blood biochemical index:blood glucose
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
blood biochemical index:uric acid
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
blood biochemical index:urea
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
blood biochemical index:creatinine
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
blood biochemical index:C reactive protein
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
blood biochemical index:d dime
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Drug treatment
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Surgery type
Time Frame: These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
|
|
Prognosis information: all-cause death
Time Frame: These data is collected during follow-up visit at 3/6/12 months after discharge
|
These data is collected during follow-up visit at 3/6/12 months after discharge
|
|
Prognosis information: whether recidivation happened
Time Frame: These data is collected during follow-up visit at 3/6/12 months after discharge
|
These data is collected during follow-up visit at 3/6/12 months after discharge
|
|
Prognosis information including: whether other related disease happened
Time Frame: These data is collected during follow-up visit at 3/6/12 months after discharge
|
These data is collected during follow-up visit at 3/6/12 months after discharge
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BeijingIHLBVD2016017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aneurysm, Dissecting
-
NCT00878371CompletedDissecting Aneurysm of the Thoracic Aorta
-
NCT02678728CompletedDissecting Aneurysm of the Thoracic Aorta | Chronic Dissecting Aneurysm of Thoracic Aorta | Chronic Nontraumatic Dissection of Thoracic Aorta
-
NCT03940859Unknown
-
NCT04943783RecruitingDissecting Aneurysm of Cerebral Artery | Inflammation Vascular | Intramural Hematomas
-
NCT02914288UnknownCerebral Arterial Diseases | Intimal Dissection | Dissecting Aneurysm of Cerebral Artery
-
NCT05803564RecruitingThoracoabdominal; Aortic, Aneurysm, Dissecting
-
NCT06405971RecruitingDissecting Aneurysm of Cerebral Artery
-
NCT04450433UnknownAortic Dissection